Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Collaborating in Innovative Medical R&D to combat the pandemic, Alphamab Oncology and Institut Pasteur Shanghai Announce Partnership to Co-develop COVID-19 Neutralizing Antibody 2020-06-10 08:40
L.E.A.F. Pharmaceuticals Lead Investigational Product for Lung and Colorectal Cancers, LEAF-1401, Featured at the 2020 Virtual Annual Meeting of the American Society of Clinical Oncology (ASCO) 2020-06-10 03:15
Alphamab Oncology and Sanofi Enter Collaboration on KN026 in HER2+ Breast Cancer 2020-06-09 10:10
Atomo and NG Biotech expand COVID-19 partnership: Atomo secures exclusive rights for Australia, New Zealand and South East Asia[1] 2020-06-09 08:02
WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States 2020-06-09 08:00
Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies 2020-06-09 07:30
Innovent and Roche Enter into A Strategic Collaboration to Discover and Develop Multiple Products including Cellular Therapies and Bispecific Antibodies 2020-06-09 07:30
Antengene Corporation Appoints Mr. Donald Lung as Chief Financial Officer 2020-06-08 20:00
Samsung Biologics Unveils Virtual Exhibition Hall to Digitally Connect with Clients at BIO 2020 2020-06-08 19:00
Healios Successfully Establishes Proprietary Universal Donor Cell Research Line 2020-06-05 13:00
IPP Announces AGC Biologics Acquisition of AstraZeneca Boulder, CO Plant 2020-06-04 21:34
Servier Completes the Acquisition of Symphogen 2020-06-04 21:30
PharmAbcine signs a license agreement with Wincal Biopharm to expand indications of PharmAbcine's existing assets to non-oncology areas 2020-06-04 00:00
Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine 2020-06-03 19:00
New Small Cell Lung Cancer Drug Accepted for TGA Evaluation Under Project Orbis 2020-06-03 14:30
Eleva's Drug Candidate to Be Examined for Use in COVID-19 Treatment 2020-06-03 10:00
Innovent Announces the Preliminary Results of the Anti-CTLA-4 Monoclonal Antibody IBI310 in a Phase 1 Clinical Study 2020-06-03 07:30
Firmenich Appoints Boet Brinkgreve as President Ingredients 2020-06-03 00:14
Firmenich Appoints Boet Brinkgreve as President Ingredients 2020-06-02 23:41
Tigermed Lauded by Frost & Sullivan for Its Rapid, Large-Scale Clinical Developmental Services 2020-06-02 22:00
1 289 290 291 292 293 451